Liminal BioSciences Inc. PFSCF

Primary Symbol: LMNL

Healthcare Biotechnology

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.

NDAQ:LMNL - Post by User

Liminal BioSciences Inc. > All the the information you need...

<< Previous

Bullboard Posts

Next >>

Comment by GunnerGon Feb 18, 2020 9:23am

71 Views

Post# 30702180

RE:All the the information you need...

Yes foof, and like the previous management they can not get those process changes done and Ryplazim (correct spelling) across the FDA finish line. Original BLA filed April 5, 2017 with priority review.

Two years and still no announcement on process change completion.

foofadooo wrote:
Remember one thing ......weather you buy or sell.....it is you and you alone that pushes the key on that decision. Remember one other thing .......the drugs are effective and badly needed by many people..... https://archive.fast-edgar.com//20191112/AU2LK22EZZ2RR2ZZ2RZN2CXJQUNHZZ22Z2BG/

foof